
Reset all filters
01 8Rozerem
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 149
2018 Revenue in Millions : 157
Growth (%) : -5
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 116
2019 Revenue in Millions : 152
Growth (%) : -24
Main Therapeutic Indication : Sleep
Currency : USD
2021 Revenue in Millions : 100
2020 Revenue in Millions : 111
Growth (%) : -2
Main Therapeutic Indication : Sleep
Currency : USD
2022 Revenue in Millions : 77
2021 Revenue in Millions : 100
Growth (%) : -23
Main Therapeutic Indication : Sleep
Currency : USD
2023 Revenue in Millions : 6
2022 Revenue in Millions : 17
Growth (%) : -59
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 71
2015 Revenue in Millions : 66
Growth (%) : 8
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 84
2016 Revenue in Millions : 76
Growth (%) : 11
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 84
2017 Revenue in Millions : 79
Growth (%) : 6%